Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

SML0198

Sigma-Aldrich

Fenoldopam mesylate

≥98% (HPLC)

Synonyme(s) :

Fenoldopam methanesulfonate

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C16H16ClNO3 · CH4O3S
Numéro CAS:
67227-57-0
Poids moléculaire :
401.86
Numéro CE :
266-612-7
Numéro MDL:
MFCD04112986
Code UNSPSC :
12352200
ID de substance PubChem :
329825223
Nomenclature NACRES :
NA.77

Niveau de qualité

100

Pureté

≥98% (HPLC)

Forme

powder

Conditions de stockage

desiccated

Couleur

white to tan

Pf

271 °C (lit.)

Solubilité

DMSO: ≥15 mg/mL at ~60 °C

Température de stockage

room temp

Chaîne SMILES 

CS(O)(=O)=O.Oc1ccc(cc1)C2CNCCc3c(Cl)c(O)c(O)cc23

InChI

1S/C16H16ClNO3.CH4O3S/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21;1-5(2,3)4/h1-4,7,13,18-21H,5-6,8H2;1H3,(H,2,3,4)

Clé InChI

CVKUMNRCIJMVAR-UHFFFAOYSA-N

Informations sur le gène

human ... DRD1(1812)

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Application

Fenoldopam mesylate may be used to study dopamine D1-mediated cell signaling.

Actions biochimiques/physiologiques

Fenoldopam mesylate (FM) is considered as an effective therapeutic agent to prevent the onset of postoperative AKI (PO-AKI). In healthy cats, FM can stimulate diuresis and be well-tolerated. This benzazepine-derivative is regional specific and does not cause cerebral vasodilation.
Fenoldopam mesylate is a selective dopamine D1 receptor agonist used as an antihypertensive agent. It is an agonist for D1-like dopamine receptors and binds with moderate affinity to α2-adrenoceptors. It has no significant affinity for D2-like receptors, α1 and α-adrenoceptors, 5HT1 and 5HT2 receptors, or muscarinic receptors. Fenoldopam mesylate causes peripheral vasodilation by stimulating dopamine-1receptors and α2-adrenoceptors, increasing renal blood flow.

Caractéristiques et avantages

This compound is featured on the Dopamine Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

Pictogrammes

Exclamation mark
GHS07

Mention d'avertissement

Warning

Mentions de danger

H302,H317,H319

Classification des risques

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Sens. 1

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients
Hammer GB, et al.
BMC anesthesiology, 8(1), 6-6 (2008)
The pharmacokinetics of intravenous fenoldopam in healthy, awake cats
O'Neill KE, et al.
Journal of Veterinary Pharmacology and Therapeutics, 39, 202-204 (2016)
C A Bloom et al.
Journal of veterinary pharmacology and therapeutics, 35(3), 224-230 (2011-07-08)
Fenoldopam is a selective dopamine-1 receptor agonist that causes peripheral arterial vasodilation, increased renal blood flow, and diuresis. Enthusiasm exists for the use of fenoldopam in nonpolyuric kidney injury in dogs, although pharmacokinetic data are lacking. The purpose of this
Sagar U Nigwekar et al.
Seminars in nephrology, 31(6), 523-534 (2011-11-22)
Acute kidney injury (AKI) is common in hospitalized patients and is associated with significant morbidity and mortality. The incidence of AKI is increasing and despite clinical advances there has been little change in the outcomes associated with AKI. A variety
John H Rundback et al.
Journal of vascular surgery, 54(2), 575-579 (2011-07-12)
Contrast-induced nephropathy (CIN) has been extensively studied since the 1950s due, in part, to its devastating adverse events. The intellectual push for additional investigation into pathogenesis and prevention has heightened in recent years due to increased utilization of contrast enhanced
Afficher tous les articles scientifiques apparentés

Articles

Dopamine Receptors

We offer many products related to dopamine receptors for your research needs.

Dopamine Receptors

We offer many products related to dopamine receptors for your research needs.

Dopamine Receptors

We offer many products related to dopamine receptors for your research needs.

Dopamine Receptors

We offer many products related to dopamine receptors for your research needs.

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique